POSC280 Economic Evaluation of Nivolumab Plus Ipilimumab in Advanced Renal-Cell Carcinoma in Japan
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.917
https://www.valueinhealthjournal.com/article/S1098-3015(21)02712-1/fulltext
Section Title :
Section Order :
10446
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02712-1&doi=10.1016/j.jval.2021.11.917